Project Details
Description
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of Instillation of MitoGel on Ablation of Urothelial Carcinoma Lesions in the Upper Urinary Tract
| Status | Finished |
|---|---|
| Effective start/end date | 12/1/16 → 11/30/19 |
Funding
- UROGEN PHARMACEUTICALS, LTD.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.